aluates Reports

$ 0.0

Automative

Global Dabigatran Etexilate Mesylate Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-11I7591

Global and China Dabigatran Etexilate Mesylate Market Insights Forecast to 2027

BUY CHAPTERS

Global Dabigatran Etexilate Mesylate Market Research Report 2024

Code: QYRE-Auto-11I7591

Report

February 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Polpharma

Apotex Pharmachem

Dr. Reddy's

Jubilant Pharma

Mehta API

Vasudha Pharma Chem

TAPI (Teva)

Metrochem

Langfang Gaobo Jingband Pharmaceutical

Lee Pharma

Qilu Pharmaceutical

Dabigatran Etexilate Mesylate Market

Dabigatran etexilate is a direct thrombin inhibitor and is the main active principle in plasma. Thrombin enables the conversion of fibrinogen into fibrin during the coagulation cascade. Inhibition of thrombin prevents the development of thrombus. Dabigatran also inhibits free thrombin, fibrin-bound thrombin and thrombin-induced platelet aggregation.

The global Dabigatran Etexilate Mesylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Dabigatran Etexilate Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Dabigatran Etexilate Mesylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Dabigatran Etexilate Mesylate include Polpharma, Apotex Pharmachem, Dr. Reddy’s, Jubilant Pharma, Mehta API, Vasudha Pharma Chem, Tapi Teva, Metrochem and Langfang Gaobo Jingband Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Dabigatran Etexilate Mesylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dabigatran Etexilate Mesylate.

Report Scope

The Dabigatran Etexilate Mesylate market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dabigatran Etexilate Mesylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dabigatran Etexilate Mesylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dabigatran Etexilate Mesylate Market Report

Report Metric	Details
Report Name	Dabigatran Etexilate Mesylate Market
Segment by Type	Purity≥98% Purity≥99%
Segment by Application	Dabigatran Etexilate Mesylate Capsule Other
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Polpharma, Apotex Pharmachem, Dr. Reddy’s, Jubilant Pharma, Mehta API, Vasudha Pharma Chem, Tapi Teva, Metrochem, Langfang Gaobo Jingband Pharmaceutical, Lee Pharma, Qilu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dabigatran Etexilate Mesylate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Dabigatran Etexilate Mesylate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Dabigatran Etexilate Mesylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dabigatran Etexilate Mesylate Market report?

Ans: The main players in the Dabigatran Etexilate Mesylate Market are Polpharma, Apotex Pharmachem, Dr. Reddy’s, Jubilant Pharma, Mehta API, Vasudha Pharma Chem, Tapi Teva, Metrochem, Langfang Gaobo Jingband Pharmaceutical, Lee Pharma, Qilu Pharmaceutical

What are the Application segmentation covered in the Dabigatran Etexilate Mesylate Market report?

Ans: The Applications covered in the Dabigatran Etexilate Mesylate Market report are Dabigatran Etexilate Mesylate Capsule, Other

What are the Type segmentation covered in the Dabigatran Etexilate Mesylate Market report?

Ans: The Types covered in the Dabigatran Etexilate Mesylate Market report are Purity≥98%, Purity≥99%

1 Dabigatran Etexilate Mesylate Market Overview

1.1 Product Definition

1.2 Dabigatran Etexilate Mesylate Segment by Type

1.2.1 Global Dabigatran Etexilate Mesylate Market Value Growth Rate Analysis by Type 2023 VS 2030

1.2.2 Purity≥98%

1.2.3 Purity≥99%

1.3 Dabigatran Etexilate Mesylate Segment by Application

1.3.1 Global Dabigatran Etexilate Mesylate Market Value Growth Rate Analysis by Application: 2023 VS 2030

1.3.2 Dabigatran Etexilate Mesylate Capsule

1.3.3 Other

1.4 Global Market Growth Prospects

1.4.1 Global Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)

1.4.2 Global Dabigatran Etexilate Mesylate Production Capacity Estimates and Forecasts (2019-2030)

1.4.3 Global Dabigatran Etexilate Mesylate Production Estimates and Forecasts (2019-2030)

1.4.4 Global Dabigatran Etexilate Mesylate Market Average Price Estimates and Forecasts (2019-2030)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Dabigatran Etexilate Mesylate Production Market Share by Manufacturers (2019-2024)

2.2 Global Dabigatran Etexilate Mesylate Production Value Market Share by Manufacturers (2019-2024)

2.3 Global Key Players of Dabigatran Etexilate Mesylate, Industry Ranking, 2022 VS 2023 VS 2024

2.4 Global Dabigatran Etexilate Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.5 Global Dabigatran Etexilate Mesylate Average Price by Manufacturers (2019-2024)

2.6 Global Key Manufacturers of Dabigatran Etexilate Mesylate, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Dabigatran Etexilate Mesylate, Product Offered and Application

2.8 Global Key Manufacturers of Dabigatran Etexilate Mesylate, Date of Enter into This Industry

2.9 Dabigatran Etexilate Mesylate Market Competitive Situation and Trends

2.9.1 Dabigatran Etexilate Mesylate Market Concentration Rate

2.9.2 Global 5 and 10 Largest Dabigatran Etexilate Mesylate Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Dabigatran Etexilate Mesylate Production by Region

3.1 Global Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.2 Global Dabigatran Etexilate Mesylate Production Value by Region (2019-2030)

3.2.1 Global Dabigatran Etexilate Mesylate Production Value Market Share by Region (2019-2024)

3.2.2 Global Forecasted Production Value of Dabigatran Etexilate Mesylate by Region (2025-2030)

3.3 Global Dabigatran Etexilate Mesylate Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

3.4 Global Dabigatran Etexilate Mesylate Production by Region (2019-2030)

3.4.1 Global Dabigatran Etexilate Mesylate Production Market Share by Region (2019-2024)

3.4.2 Global Forecasted Production of Dabigatran Etexilate Mesylate by Region (2025-2030)

3.5 Global Dabigatran Etexilate Mesylate Market Price Analysis by Region (2019-2024)

3.6 Global Dabigatran Etexilate Mesylate Production and Value, Year-over-Year Growth

3.6.1 North America Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)

3.6.2 Europe Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)

3.6.3 China Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)

3.6.4 Japan Dabigatran Etexilate Mesylate Production Value Estimates and Forecasts (2019-2030)

4 Dabigatran Etexilate Mesylate Consumption by Region

4.1 Global Dabigatran Etexilate Mesylate Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030

4.2 Global Dabigatran Etexilate Mesylate Consumption by Region (2019-2030)

4.2.1 Global Dabigatran Etexilate Mesylate Consumption by Region (2019-2024)

4.2.2 Global Dabigatran Etexilate Mesylate Forecasted Consumption by Region (2025-2030)

4.3 North America

4.3.1 North America Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.3.2 North America Dabigatran Etexilate Mesylate Consumption by Country (2019-2030)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.4.2 Europe Dabigatran Etexilate Mesylate Consumption by Country (2019-2030)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Dabigatran Etexilate Mesylate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030

4.5.2 Asia Pacific Dabigatran Etexilate Mesylate Consumption by Region (2019-2030)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030

4.6.2 Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption by Country (2019-2030)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

5 Segment by Type

5.1 Global Dabigatran Etexilate Mesylate Production by Type (2019-2030)

5.1.1 Global Dabigatran Etexilate Mesylate Production by Type (2019-2024)

5.1.2 Global Dabigatran Etexilate Mesylate Production by Type (2025-2030)

5.1.3 Global Dabigatran Etexilate Mesylate Production Market Share by Type (2019-2030)

5.2 Global Dabigatran Etexilate Mesylate Production Value by Type (2019-2030)

5.2.1 Global Dabigatran Etexilate Mesylate Production Value by Type (2019-2024)

5.2.2 Global Dabigatran Etexilate Mesylate Production Value by Type (2025-2030)

5.2.3 Global Dabigatran Etexilate Mesylate Production Value Market Share by Type (2019-2030)

5.3 Global Dabigatran Etexilate Mesylate Price by Type (2019-2030)

6 Segment by Application

6.1 Global Dabigatran Etexilate Mesylate Production by Application (2019-2030)

6.1.1 Global Dabigatran Etexilate Mesylate Production by Application (2019-2024)

6.1.2 Global Dabigatran Etexilate Mesylate Production by Application (2025-2030)

6.1.3 Global Dabigatran Etexilate Mesylate Production Market Share by Application (2019-2030)

6.2 Global Dabigatran Etexilate Mesylate Production Value by Application (2019-2030)

6.2.1 Global Dabigatran Etexilate Mesylate Production Value by Application (2019-2024)

6.2.2 Global Dabigatran Etexilate Mesylate Production Value by Application (2025-2030)

6.2.3 Global Dabigatran Etexilate Mesylate Production Value Market Share by Application (2019-2030)

6.3 Global Dabigatran Etexilate Mesylate Price by Application (2019-2030)

7 Key Companies Profiled

7.1 Polpharma

7.1.1 Polpharma Dabigatran Etexilate Mesylate Corporation Information

7.1.2 Polpharma Dabigatran Etexilate Mesylate Product Portfolio

7.1.3 Polpharma Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.1.4 Polpharma Main Business and Markets Served

7.1.5 Polpharma Recent Developments/Updates

7.2 Apotex Pharmachem

7.2.1 Apotex Pharmachem Dabigatran Etexilate Mesylate Corporation Information

7.2.2 Apotex Pharmachem Dabigatran Etexilate Mesylate Product Portfolio

7.2.3 Apotex Pharmachem Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.2.4 Apotex Pharmachem Main Business and Markets Served

7.2.5 Apotex Pharmachem Recent Developments/Updates

7.3 Dr. Reddy’s

7.3.1 Dr. Reddy’s Dabigatran Etexilate Mesylate Corporation Information

7.3.2 Dr. Reddy’s Dabigatran Etexilate Mesylate Product Portfolio

7.3.3 Dr. Reddy’s Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.3.4 Dr. Reddy’s Main Business and Markets Served

7.3.5 Dr. Reddy’s Recent Developments/Updates

7.4 Jubilant Pharma

7.4.1 Jubilant Pharma Dabigatran Etexilate Mesylate Corporation Information

7.4.2 Jubilant Pharma Dabigatran Etexilate Mesylate Product Portfolio

7.4.3 Jubilant Pharma Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.4.4 Jubilant Pharma Main Business and Markets Served

7.4.5 Jubilant Pharma Recent Developments/Updates

7.5 Mehta API

7.5.1 Mehta API Dabigatran Etexilate Mesylate Corporation Information

7.5.2 Mehta API Dabigatran Etexilate Mesylate Product Portfolio

7.5.3 Mehta API Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.5.4 Mehta API Main Business and Markets Served

7.5.5 Mehta API Recent Developments/Updates

7.6 Vasudha Pharma Chem

7.6.1 Vasudha Pharma Chem Dabigatran Etexilate Mesylate Corporation Information

7.6.2 Vasudha Pharma Chem Dabigatran Etexilate Mesylate Product Portfolio

7.6.3 Vasudha Pharma Chem Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.6.4 Vasudha Pharma Chem Main Business and Markets Served

7.6.5 Vasudha Pharma Chem Recent Developments/Updates

7.7 Tapi Teva

7.7.1 Tapi Teva Dabigatran Etexilate Mesylate Corporation Information

7.7.2 Tapi Teva Dabigatran Etexilate Mesylate Product Portfolio

7.7.3 Tapi Teva Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.7.4 Tapi Teva Main Business and Markets Served

7.7.5 Tapi Teva Recent Developments/Updates

7.8 Metrochem

7.8.1 Metrochem Dabigatran Etexilate Mesylate Corporation Information

7.8.2 Metrochem Dabigatran Etexilate Mesylate Product Portfolio

7.8.3 Metrochem Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.8.4 Metrochem Main Business and Markets Served

7.7.5 Metrochem Recent Developments/Updates

7.9 Langfang Gaobo Jingband Pharmaceutical

7.9.1 Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Corporation Information

7.9.2 Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Product Portfolio

7.9.3 Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.9.4 Langfang Gaobo Jingband Pharmaceutical Main Business and Markets Served

7.9.5 Langfang Gaobo Jingband Pharmaceutical Recent Developments/Updates

7.10 Lee Pharma

7.10.1 Lee Pharma Dabigatran Etexilate Mesylate Corporation Information

7.10.2 Lee Pharma Dabigatran Etexilate Mesylate Product Portfolio

7.10.3 Lee Pharma Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.10.4 Lee Pharma Main Business and Markets Served

7.10.5 Lee Pharma Recent Developments/Updates

7.11 Qilu Pharmaceutical

7.11.1 Qilu Pharmaceutical Dabigatran Etexilate Mesylate Corporation Information

7.11.2 Qilu Pharmaceutical Dabigatran Etexilate Mesylate Product Portfolio

7.11.3 Qilu Pharmaceutical Dabigatran Etexilate Mesylate Production, Value, Price and Gross Margin (2019-2024)

7.11.4 Qilu Pharmaceutical Main Business and Markets Served

7.11.5 Qilu Pharmaceutical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Dabigatran Etexilate Mesylate Industry Chain Analysis

8.2 Dabigatran Etexilate Mesylate Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Dabigatran Etexilate Mesylate Production Mode & Process

8.4 Dabigatran Etexilate Mesylate Sales and Marketing

8.4.1 Dabigatran Etexilate Mesylate Sales Channels

8.4.2 Dabigatran Etexilate Mesylate Distributors

8.5 Dabigatran Etexilate Mesylate Customers

9 Dabigatran Etexilate Mesylate Market Dynamics

9.1 Dabigatran Etexilate Mesylate Industry Trends

9.2 Dabigatran Etexilate Mesylate Market Drivers

9.3 Dabigatran Etexilate Mesylate Market Challenges

9.4 Dabigatran Etexilate Mesylate Market Restraints

10 Research Finding and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Polpharma

Apotex Pharmachem

Dr. Reddy's

Jubilant Pharma

Mehta API

Vasudha Pharma Chem

TAPI (Teva)

Metrochem

Langfang Gaobo Jingband Pharmaceutical

Lee Pharma

Qilu Pharmaceutical

List of Tables

Table 1. Global Dabigatran Etexilate Mesylate Market Value by Type, (US$ Million) & (2023 VS 2030)

Table 2. Global Dabigatran Etexilate Mesylate Market Value by Application, (US$ Million) & (2023 VS 2030)

Table 3. Global Dabigatran Etexilate Mesylate Production Capacity (MT) by Manufacturers in 2023

Table 4. Global Dabigatran Etexilate Mesylate Production by Manufacturers (2019-2024) & (MT)

Table 5. Global Dabigatran Etexilate Mesylate Production Market Share by Manufacturers (2019-2024)

Table 6. Global Dabigatran Etexilate Mesylate Production Value by Manufacturers (2019-2024) & (US$ Million)

Table 7. Global Dabigatran Etexilate Mesylate Production Value Share by Manufacturers (2019-2024)

Table 8. Global Dabigatran Etexilate Mesylate Industry Ranking 2022 VS 2023 VS 2024

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dabigatran Etexilate Mesylate as of 2023)

Table 10. Global Market Dabigatran Etexilate Mesylate Average Price by Manufacturers (USD/Kg) & (2019-2024)

Table 11. Manufacturers Dabigatran Etexilate Mesylate Production Sites and Area Served

Table 12. Manufacturers Dabigatran Etexilate Mesylate Product Types

Table 13. Global Dabigatran Etexilate Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Dabigatran Etexilate Mesylate Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 16. Global Dabigatran Etexilate Mesylate Production Value (US$ Million) by Region (2019-2024)

Table 17. Global Dabigatran Etexilate Mesylate Production Value Market Share by Region (2019-2024)

Table 18. Global Dabigatran Etexilate Mesylate Production Value (US$ Million) Forecast by Region (2025-2030)

Table 19. Global Dabigatran Etexilate Mesylate Production Value Market Share Forecast by Region (2025-2030)

Table 20. Global Dabigatran Etexilate Mesylate Production Comparison by Region: 2019 VS 2023 VS 2030 (MT)

Table 21. Global Dabigatran Etexilate Mesylate Production (MT) by Region (2019-2024)

Table 22. Global Dabigatran Etexilate Mesylate Production Market Share by Region (2019-2024)

Table 23. Global Dabigatran Etexilate Mesylate Production (MT) Forecast by Region (2025-2030)

Table 24. Global Dabigatran Etexilate Mesylate Production Market Share Forecast by Region (2025-2030)

Table 25. Global Dabigatran Etexilate Mesylate Market Average Price (USD/Kg) by Region (2019-2024)

Table 26. Global Dabigatran Etexilate Mesylate Market Average Price (USD/Kg) by Region (2025-2030)

Table 27. Global Dabigatran Etexilate Mesylate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (MT)

Table 28. Global Dabigatran Etexilate Mesylate Consumption by Region (2019-2024) & (MT)

Table 29. Global Dabigatran Etexilate Mesylate Consumption Market Share by Region (2019-2024)

Table 30. Global Dabigatran Etexilate Mesylate Forecasted Consumption by Region (2025-2030) & (MT)

Table 31. Global Dabigatran Etexilate Mesylate Forecasted Consumption Market Share by Region (2019-2024)

Table 32. North America Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)

Table 33. North America Dabigatran Etexilate Mesylate Consumption by Country (2019-2024) & (MT)

Table 34. North America Dabigatran Etexilate Mesylate Consumption by Country (2025-2030) & (MT)

Table 35. Europe Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)

Table 36. Europe Dabigatran Etexilate Mesylate Consumption by Country (2019-2024) & (MT)

Table 37. Europe Dabigatran Etexilate Mesylate Consumption by Country (2025-2030) & (MT)

Table 38. Asia Pacific Dabigatran Etexilate Mesylate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (MT)

Table 39. Asia Pacific Dabigatran Etexilate Mesylate Consumption by Region (2019-2024) & (MT)

Table 40. Asia Pacific Dabigatran Etexilate Mesylate Consumption by Region (2025-2030) & (MT)

Table 41. Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (MT)

Table 42. Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption by Country (2019-2024) & (MT)

Table 43. Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption by Country (2025-2030) & (MT)

Table 44. Global Dabigatran Etexilate Mesylate Production (MT) by Type (2019-2024)

Table 45. Global Dabigatran Etexilate Mesylate Production (MT) by Type (2025-2030)

Table 46. Global Dabigatran Etexilate Mesylate Production Market Share by Type (2019-2024)

Table 47. Global Dabigatran Etexilate Mesylate Production Market Share by Type (2025-2030)

Table 48. Global Dabigatran Etexilate Mesylate Production Value (US$ Million) by Type (2019-2024)

Table 49. Global Dabigatran Etexilate Mesylate Production Value (US$ Million) by Type (2025-2030)

Table 50. Global Dabigatran Etexilate Mesylate Production Value Share by Type (2019-2024)

Table 51. Global Dabigatran Etexilate Mesylate Production Value Share by Type (2025-2030)

Table 52. Global Dabigatran Etexilate Mesylate Price (USD/Kg) by Type (2019-2024)

Table 53. Global Dabigatran Etexilate Mesylate Price (USD/Kg) by Type (2025-2030)

Table 54. Global Dabigatran Etexilate Mesylate Production (MT) by Application (2019-2024)

Table 55. Global Dabigatran Etexilate Mesylate Production (MT) by Application (2025-2030)

Table 56. Global Dabigatran Etexilate Mesylate Production Market Share by Application (2019-2024)

Table 57. Global Dabigatran Etexilate Mesylate Production Market Share by Application (2025-2030)

Table 58. Global Dabigatran Etexilate Mesylate Production Value (US$ Million) by Application (2019-2024)

Table 59. Global Dabigatran Etexilate Mesylate Production Value (US$ Million) by Application (2025-2030)

Table 60. Global Dabigatran Etexilate Mesylate Production Value Share by Application (2019-2024)

Table 61. Global Dabigatran Etexilate Mesylate Production Value Share by Application (2025-2030)

Table 62. Global Dabigatran Etexilate Mesylate Price (USD/Kg) by Application (2019-2024)

Table 63. Global Dabigatran Etexilate Mesylate Price (USD/Kg) by Application (2025-2030)

Table 64. Polpharma Dabigatran Etexilate Mesylate Corporation Information

Table 65. Polpharma Specification and Application

Table 66. Polpharma Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 67. Polpharma Main Business and Markets Served

Table 68. Polpharma Recent Developments/Updates

Table 69. Apotex Pharmachem Dabigatran Etexilate Mesylate Corporation Information

Table 70. Apotex Pharmachem Specification and Application

Table 71. Apotex Pharmachem Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 72. Apotex Pharmachem Main Business and Markets Served

Table 73. Apotex Pharmachem Recent Developments/Updates

Table 74. Dr. Reddy’s Dabigatran Etexilate Mesylate Corporation Information

Table 75. Dr. Reddy’s Specification and Application

Table 76. Dr. Reddy’s Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 77. Dr. Reddy’s Main Business and Markets Served

Table 78. Dr. Reddy’s Recent Developments/Updates

Table 79. Jubilant Pharma Dabigatran Etexilate Mesylate Corporation Information

Table 80. Jubilant Pharma Specification and Application

Table 81. Jubilant Pharma Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 82. Jubilant Pharma Main Business and Markets Served

Table 83. Jubilant Pharma Recent Developments/Updates

Table 84. Mehta API Dabigatran Etexilate Mesylate Corporation Information

Table 85. Mehta API Specification and Application

Table 86. Mehta API Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 87. Mehta API Main Business and Markets Served

Table 88. Mehta API Recent Developments/Updates

Table 89. Vasudha Pharma Chem Dabigatran Etexilate Mesylate Corporation Information

Table 90. Vasudha Pharma Chem Specification and Application

Table 91. Vasudha Pharma Chem Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 92. Vasudha Pharma Chem Main Business and Markets Served

Table 93. Vasudha Pharma Chem Recent Developments/Updates

Table 94. Tapi Teva Dabigatran Etexilate Mesylate Corporation Information

Table 95. Tapi Teva Specification and Application

Table 96. Tapi Teva Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 97. Tapi Teva Main Business and Markets Served

Table 98. Tapi Teva Recent Developments/Updates

Table 99. Metrochem Dabigatran Etexilate Mesylate Corporation Information

Table 100. Metrochem Specification and Application

Table 101. Metrochem Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 102. Metrochem Main Business and Markets Served

Table 103. Metrochem Recent Developments/Updates

Table 104. Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Corporation Information

Table 105. Langfang Gaobo Jingband Pharmaceutical Specification and Application

Table 106. Langfang Gaobo Jingband Pharmaceutical Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 107. Langfang Gaobo Jingband Pharmaceutical Main Business and Markets Served

Table 108. Langfang Gaobo Jingband Pharmaceutical Recent Developments/Updates

Table 109. Lee Pharma Dabigatran Etexilate Mesylate Corporation Information

Table 110. Lee Pharma Specification and Application

Table 111. Lee Pharma Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 112. Lee Pharma Main Business and Markets Served

Table 113. Lee Pharma Recent Developments/Updates

Table 114. Qilu Pharmaceutical Dabigatran Etexilate Mesylate Corporation Information

Table 115. Qilu Pharmaceutical Specification and Application

Table 116. Qilu Pharmaceutical Dabigatran Etexilate Mesylate Production (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 117. Qilu Pharmaceutical Main Business and Markets Served

Table 118. Qilu Pharmaceutical Recent Developments/Updates

Table 119. Key Raw Materials Lists

Table 120. Raw Materials Key Suppliers Lists

Table 121. Dabigatran Etexilate Mesylate Distributors List

Table 122. Dabigatran Etexilate Mesylate Customers List

Table 123. Dabigatran Etexilate Mesylate Market Trends

Table 124. Dabigatran Etexilate Mesylate Market Drivers

Table 125. Dabigatran Etexilate Mesylate Market Challenges

Table 126. Dabigatran Etexilate Mesylate Market Restraints

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Dabigatran Etexilate Mesylate

Figure 2. Global Dabigatran Etexilate Mesylate Market Value by Type, (US$ Million) & (2023 VS 2030)

Figure 3. Global Dabigatran Etexilate Mesylate Market Share by Type: 2023 VS 2030

Figure 4. Purity≥98% Product Picture

Figure 5. Purity≥99% Product Picture

Figure 6. Global Dabigatran Etexilate Mesylate Market Value by Application, (US$ Million) & (2023 VS 2030)

Figure 7. Global Dabigatran Etexilate Mesylate Market Share by Application: 2023 VS 2030

Figure 8. Dabigatran Etexilate Mesylate Capsule

Figure 9. Other

Figure 10. Global Dabigatran Etexilate Mesylate Production Value (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Dabigatran Etexilate Mesylate Production Value (US$ Million) & (2019-2030)

Figure 12. Global Dabigatran Etexilate Mesylate Production Capacity (MT) & (2019-2030)

Figure 13. Global Dabigatran Etexilate Mesylate Production (MT) & (2019-2030)

Figure 14. Global Dabigatran Etexilate Mesylate Average Price (USD/Kg) & (2019-2030)

Figure 15. Dabigatran Etexilate Mesylate Report Years Considered

Figure 16. Dabigatran Etexilate Mesylate Production Share by Manufacturers in 2023

Figure 17. Dabigatran Etexilate Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 18. The Global 5 and 10 Largest Players: Market Share by Dabigatran Etexilate Mesylate Revenue in 2023

Figure 19. Global Dabigatran Etexilate Mesylate Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 20. Global Dabigatran Etexilate Mesylate Production Value Market Share by Region: 2019 VS 2023 VS 2030

Figure 21. Global Dabigatran Etexilate Mesylate Production Comparison by Region: 2019 VS 2023 VS 2030 (MT)

Figure 22. Global Dabigatran Etexilate Mesylate Production Market Share by Region: 2019 VS 2023 VS 2030

Figure 23. North America Dabigatran Etexilate Mesylate Production Value (US$ Million) Growth Rate (2019-2030)

Figure 24. Europe Dabigatran Etexilate Mesylate Production Value (US$ Million) Growth Rate (2019-2030)

Figure 25. China Dabigatran Etexilate Mesylate Production Value (US$ Million) Growth Rate (2019-2030)

Figure 26. Japan Dabigatran Etexilate Mesylate Production Value (US$ Million) Growth Rate (2019-2030)

Figure 27. Global Dabigatran Etexilate Mesylate Consumption by Region: 2019 VS 2023 VS 2030 (MT)

Figure 28. Global Dabigatran Etexilate Mesylate Consumption Market Share by Region: 2019 VS 2023 VS 2030

Figure 29. North America Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 30. North America Dabigatran Etexilate Mesylate Consumption Market Share by Country (2019-2030)

Figure 31. Canada Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 32. U.S. Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 33. Europe Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 34. Europe Dabigatran Etexilate Mesylate Consumption Market Share by Country (2019-2030)

Figure 35. Germany Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 36. France Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 37. U.K. Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 38. Italy Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 39. Russia Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 40. Asia Pacific Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 41. Asia Pacific Dabigatran Etexilate Mesylate Consumption Market Share by Regions (2019-2030)

Figure 42. China Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 43. Japan Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 44. South Korea Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 45. China Taiwan Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 46. Southeast Asia Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 47. India Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 48. Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 49. Latin America, Middle East & Africa Dabigatran Etexilate Mesylate Consumption Market Share by Country (2019-2030)

Figure 50. Mexico Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 51. Brazil Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 52. Turkey Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 53. GCC Countries Dabigatran Etexilate Mesylate Consumption and Growth Rate (2019-2024) & (MT)

Figure 54. Global Production Market Share of Dabigatran Etexilate Mesylate by Type (2019-2030)

Figure 55. Global Production Value Market Share of Dabigatran Etexilate Mesylate by Type (2019-2030)

Figure 56. Global Dabigatran Etexilate Mesylate Price (USD/Kg) by Type (2019-2030)

Figure 57. Global Production Market Share of Dabigatran Etexilate Mesylate by Application (2019-2030)

Figure 58. Global Production Value Market Share of Dabigatran Etexilate Mesylate by Application (2019-2030)

Figure 59. Global Dabigatran Etexilate Mesylate Price (USD/Kg) by Application (2019-2030)

Figure 60. Dabigatran Etexilate Mesylate Value Chain

Figure 61. Dabigatran Etexilate Mesylate Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions